Clinic of Pediatric Hematology, Oncology and Stem Cell Transplantation, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Prof. Hess Children's Hospital, Klinikum Bremen-Mitte, Gesundheit Nord gGmbH, Bremen, Germany.
J Clin Immunol. 2024 May 22;44(6):129. doi: 10.1007/s10875-024-01733-6.
Mutations in genes of the DNA polymerase complex have been linked to impaired immunological function next to distinct syndromic features. Biallelic mutations in PRIM1 are associated with a primordial dwarfism syndrome with variable hypogammaglobulinemia. The disease is mostly lethal in infancy due to pulmonary infections as well as hepatic cirrhosis. We studied 3 novel patients with PRIM1-deficiency with a focus on immunological consequences. All three shared dysmorphic features including a prominent forehead, triangular face and bilateral cryptorchidism. P1 carried the novel homozygous PRIM1 splice variant c.103+2T>G, allowing residual protein expression and associated with a mild clinical phenotype. P2 and P3 carried the known homozygous variant c.638+36C>G and died in infancy. Paradoxically, B cell lymphopenia was most pronounced in P1. No other significant lymphocyte abnormalities were detected. Interestingly, all 3 patients showed variable, but intermittently excessive Type I interferon signatures. In summary, the B-cell deficiency in PRIM1-deficiency is markedly variable and the severity of syndromic manifestations is not predictive of the immunological phenotype. We highlight a potential contribution of pathological type I interferon activation to disease pathogenesis which warrants further investigations.
DNA 聚合酶复合物基因的突变与免疫功能受损以及明显的综合征特征有关。PRIM1 的双等位基因突变与可变低丙种球蛋白血症的原基性侏儒综合征有关。由于肺部感染和肝硬化,该疾病在婴儿期大多致命。我们研究了 3 名具有 PRIM1 缺陷的新型患者,重点关注免疫后果。所有三人都具有相似的畸形特征,包括突出的额头、三角脸和双侧隐睾。P1 携带新的纯合 PRIM1 剪接变体 c.103+2T>G,允许残留蛋白表达,并与轻度临床表型相关。P2 和 P3 携带已知的纯合变体 c.638+36C>G,并在婴儿期死亡。矛盾的是,P1 的 B 细胞淋巴细胞减少症最为明显。未检测到其他明显的淋巴细胞异常。有趣的是,所有 3 名患者均显示出不同程度的、但间歇性的 I 型干扰素过度表达特征。总之,PRIM1 缺陷中的 B 细胞缺陷明显不同,综合征表现的严重程度不能预测免疫表型。我们强调病理性 I 型干扰素激活对疾病发病机制的潜在贡献,值得进一步研究。